Hontiveros Questions VP Office's Use of Confidential Funds for Medicines

MANILA, Philippines — Senator Risa Hontiveros continues to question the use of confidential funds by the Office of the Vice President (OVP) for the purchase of medicines, asking whether the funds should be treated as aid rather than rewards to informants. Hontiveros raised concerns about the transparency and accountability surrounding the OVP's confidential funds, particularly focusing on whether these funds, designated for medicine purchases, were disbursed as rewards to informants or as direct aid to citizens in need. She is seeking clarification on the nature of these transactions. In the Philippines, certain government agencies, including the Office of the Vice President, are allocated confidential funds through congressional approval for sensitive operations such as national security and intelligence gathering. However, the opaque nature of these fund utilizations has consistently drawn scrutiny and calls for accountability from civil society and some lawmakers. This latest inquiry by Senator Hontiveros highlights fundamental questions about the intended purpose of confidential funds versus their actual implementation, and whether public funds are being utilized appropriately for the benefit of the citizens. The use of these funds for medicine purchases, which directly impacts public health, necessitates a higher degree of transparency. Source: Inquirer NewsInfo